Athens Medical C.S.A. (ATH:IATR)

Market Cap	177.81M
Revenue (ttm)	258.36M
Net Income (ttm)	8.08M
Shares Out	86.74M
EPS (ttm)	0.09
PE Ratio	19.61
Forward PE	n/a
Dividend	0.02 (0.98%)
Ex-Dividend Date	Jul 22, 2024

Volume	13,108
Average Volume	26,163
Open	2.050
Previous Close	2.060
Day's Range	2.020 - 2.080
52-Week Range	1.440 - 2.120
Beta	1.20
RSI	65.71
Earnings Date	May 2, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,230
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2023, Athens Medical C.S.A.'s revenue was 258.36 million, an increase of 10.69% compared to the previous year's 233.42 million. Earnings were 8.08 million, an increase of 18.05%.